TY - JOUR
T1 - Improved spillover correction model to quantify myocardial blood flow by 11C-acetate PET
T2 - comparison with 15O-H2O PET
AU - Mori, Yuki
AU - Manabe, Osamu
AU - Naya, Masanao
AU - Tomiyama, Yuuki
AU - Yoshinaga, Keiichiro
AU - Magota, Keiichi
AU - Oyama-Manabe, Noriko
AU - Hirata, Kenji
AU - Tsutsui, Hiroyuki
AU - Tamaki, Nagara
AU - Katoh, Chietsugu
N1 - Publisher Copyright:
© 2014, The Japanese Society of Nuclear Medicine.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Methods: Sixty-three subjects were examined with 11C-acetate and 15O-H2O dynamic PET at rest. Inflow rate of 11C-acetate (K1) was compared with MBF derived from 15O-H2O PET. For the derivation, the relationship between K1 and MBF from 15O-H2O was linked by the Renkin-Crone model in 20 subjects as a pilot group. One-parameter and two-parameter corrections were applied to suppress the spillover between left ventricular (LV) wall and LV cavity. Validation was set using the other 43 subjects’ data. Finally, rMBFs were calculated using relational expression derived from the pilot-group data.Objective: 11C-acetate has been applied for evaluation of myocardial oxidative metabolism and can simultaneously estimate myocardial blood flow (MBF). We developed a new method using two-parameter spillover correction to estimate regional MBF (rMBF) with 11C-acetate PET in reference to MBF derived from 15O-H2O PET. The usefulness of our new approach was evaluated compared to the conventional method using one-parameter spillover correction.Results: The relationship between K1 and MBF derived from 15O-H2O PET was approximated as K1 = [1–0.764 × exp(−1.001/MBF)] MBF from the pilot data using the two-parameter method. In the validation set, the correlation coefficient between rMBF from 11C-acetate and 15O-H2O demonstrated a significantly higher relationship with the two-parameter spillover correction method than the one-parameter spillover correction method (r = 0.730, 0.592, respectively, p < 0.05).Conclusion: In 11C-acetate PET study, the new two-parameter spillover correction method dedicated more accurate and robust myocardial blood flow than the conventional one-parameter method.
AB - Methods: Sixty-three subjects were examined with 11C-acetate and 15O-H2O dynamic PET at rest. Inflow rate of 11C-acetate (K1) was compared with MBF derived from 15O-H2O PET. For the derivation, the relationship between K1 and MBF from 15O-H2O was linked by the Renkin-Crone model in 20 subjects as a pilot group. One-parameter and two-parameter corrections were applied to suppress the spillover between left ventricular (LV) wall and LV cavity. Validation was set using the other 43 subjects’ data. Finally, rMBFs were calculated using relational expression derived from the pilot-group data.Objective: 11C-acetate has been applied for evaluation of myocardial oxidative metabolism and can simultaneously estimate myocardial blood flow (MBF). We developed a new method using two-parameter spillover correction to estimate regional MBF (rMBF) with 11C-acetate PET in reference to MBF derived from 15O-H2O PET. The usefulness of our new approach was evaluated compared to the conventional method using one-parameter spillover correction.Results: The relationship between K1 and MBF derived from 15O-H2O PET was approximated as K1 = [1–0.764 × exp(−1.001/MBF)] MBF from the pilot data using the two-parameter method. In the validation set, the correlation coefficient between rMBF from 11C-acetate and 15O-H2O demonstrated a significantly higher relationship with the two-parameter spillover correction method than the one-parameter spillover correction method (r = 0.730, 0.592, respectively, p < 0.05).Conclusion: In 11C-acetate PET study, the new two-parameter spillover correction method dedicated more accurate and robust myocardial blood flow than the conventional one-parameter method.
UR - http://www.scopus.com/inward/record.url?scp=84926005495&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84926005495&partnerID=8YFLogxK
U2 - 10.1007/s12149-014-0904-z
DO - 10.1007/s12149-014-0904-z
M3 - Article
C2 - 25209232
AN - SCOPUS:84926005495
VL - 29
SP - 15
EP - 20
JO - Annals of Nuclear Medicine
JF - Annals of Nuclear Medicine
SN - 0914-7187
IS - 1
ER -